ARCT - Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q4 2020 Results - Earnings Call Transcript
Arcturus Therapeutics Holdings Inc. (ARCT) Q4 2020 Earnings Conference Call March 01, 2021 04:30 PM ET Company Participants Neda Safarzadeh - Head-Investor Relations, Public Relations & Marketing Joseph Payne - President & Chief Executive Officer Ooi Eng Eong - Deputy Director-Emerging Infectious Diseases Programme-Duke-NUS Medical School & Arcturus Vaccine Platform Scientific-Advisory Board Steve Hughes - Chief Medical Officer Andy Sassine - Chief Financial Officer Pad Chivukula - Chief Scientific Officer & Chief Operating Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Seamus Fernandez - Guggenheim Yigal Nochomovitz - Citigroup Wangzhi Li - Ladenburg Presentation Operator Greetings, and welcome to the Arcturus Therapeutics Fourth Quarter and Full Year 2020 Earnings Call At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host Neda
For further details see:
Arcturus Therapeutics Holdings Inc. (ARCT) CEO Joseph Payne on Q4 2020 Results - Earnings Call Transcript